Cargando…

Fingolimod Promotes Antibacterial Effect of Doripenem against Carbapenem-Resistant Escherichia coli

The aim of this study was to determine whether fingolimod could synergize the antibacterial activity of doripenem against carbapenem-resistant Escherichia coli (CREC) and its potential as an antibiotic adjuvant for doripenem. The E. coli used in this study had the bla(KPC) gene and became resistant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Hye-Won, Kim, Hye-Rim, Eom, Yong-Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405376/ https://www.ncbi.nlm.nih.gov/pubmed/36009912 http://dx.doi.org/10.3390/antibiotics11081043

Ejemplares similares

Synergistic Activity of Equol and Meropenem against Carbapenem-Resistant Escherichia coli
por: Kim, Hye-Rim, et al.
Publicado: (2021)

In vitro Antibacterial Activity of Doripenem against Gram-Negative Blood Isolates in a Korean Tertiary Care Center
por: Choi, Seong-Ho, et al.
Publicado: (2015)

In vitro and in vivo efficacy study of cefepime, doripenem, tigecycline, and tetracycline against extended-spectrum beta-lactamases Escherichia coli in chickens
por: Tarazi, Yaser Hamadeh, et al.
Publicado: (2020)

Doripenem: A new carbapenem antibiotic a review of comparative antimicrobial and bactericidal activities
por: Walsh, Fiona
Publicado: (2007)

Structural Analysis of The OXA-48 Carbapenemase Bound to A “Poor” Carbapenem Substrate, Doripenem
por: Papp-Wallace, Krisztina M., et al.
Publicado: (2019)

In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa
por: Hu, Yi-Fan, et al.
Publicado: (2016)

In Vitro Antibacterial Interaction of Doripenem and Amikacin against Multidrug-Resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae Isolates
por: Loho, Tonny, et al.
Publicado: (2018)

Continuous high-dose infusion of doripenem in a pneumonia patient infected by carbapenem-resistant Pseudomonas aeruginosa: a case report
por: Oda, Kazutaka, et al.
Publicado: (2019)

Polymyxins and Doripenem Combination Against KPC-Producing Klebsiella pneumoniae
por: Lee, Grace C., et al.
Publicado: (2013)

Synergistic Antibacterial Effects of Meropenem in Combination with Aminoglycosides against Carbapenem-Resistant Escherichia coli Harboring bla(NDM-1) and bla(NDM-5)
por: Terbtothakun, Pawarisa, et al.
Publicado: (2021)

Pharmacokinetic/Pharmacodynamic (PK/PD) Simulation for Dosage Optimization of Colistin Against Carbapenem-Resistant Klebsiella pneumoniae and Carbapenem-Resistant Escherichia coli
por: Jitaree, Kamonchanok, et al.
Publicado: (2019)

Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Shi, HyeJin, et al.
Publicado: (2019)

Predictors of Mortality in Patients with Carbapenem-Resistant Gram-Negative Bacilli or Vancomycin-Resistant Enterococci Bacteremia
por: Shi, Hye Jin, et al.
Publicado: (2020)

In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii
por: Park, Gyun Cheol, et al.
Publicado: (2016)

Association of doripenem resistance with OXA-type carbapenemases in Acinetobacter baumannii isolates
por: Terzi, Huseyin-Agah, et al.
Publicado: (2016)

Characterization of Genomic Diversity among Carbapenem-Resistant Escherichia coli Clinical Isolates and Antibacterial Efficacy of Silver Nanoparticles from Pakistan
por: Gondal, Aamir Jamal, et al.
Publicado: (2022)

Proteomic Investigation of the Antibacterial Mechanism of Cefiderocol against Escherichia coli
por: Du, Gao-Fei, et al.
Publicado: (2022)

Sub lethal levels of platinum nanoparticle cures plasmid and in combination with carbapenem, curtails carbapenem resistant Escherichia coli
por: Bharathan, Subhashree, et al.
Publicado: (2019)

Genetic characterization of Carbapenem-Resistant Escherichia coli from China, 2015–2017
por: Li, Fengtian, et al.
Publicado: (2021)

Characteristics of doripenem: a new broad-spectrum antibiotic
por: Alvarez-Lerma, Francisco, et al.
Publicado: (2009)

Antibacterial Activity of Medicinal Plants against Uropathogenic Escherichia coli
por: Marouf, Razan Salman, et al.
Publicado: (2022)

Anti-biofilm and Anti-Virulence Efficacy of Celastrol Against Stenotrophomonas maltophilia
por: Kim, Hye-Rim, et al.
Publicado: (2018)

Novel quorum sensing inhibitor Echinatin as an antibacterial synergist against Escherichia coli
por: Bai, Yu-Bin, et al.
Publicado: (2022)

Synthesis and Biological Evaluation of Fingolimod Derivatives as Antibacterial Agents
por: Zore, Matej, et al.
Publicado: (2021)

Antibacterial Activity of Bacteriocinogenic Commensal Escherichia coli against Zoonotic Strains Resistant and Sensitive to Antibiotics
por: Mazurek-Popczyk, Justyna, et al.
Publicado: (2020)

Antibacterial and Antibiofilm Activities of Novel Antimicrobial Peptides against Multidrug-Resistant Enterotoxigenic Escherichia Coli
por: Wu, Kang-Chi, et al.
Publicado: (2021)

Survival of carbapenem-resistant Acinetobacter baumannii bacteremia: colistin monotherapy versus colistin plus meropenem
por: Park, So Yeon, et al.
Publicado: (2019)

In vitro Activity of Meropenem-Vaborbactam versus Other Antibiotics Against Carbapenem-Resistant Escherichia coli from Southeastern China
por: Huang, Na, et al.
Publicado: (2021)

Antibacterial mechanism of ultrasound against Escherichia coli: Alterations in membrane microstructures and properties
por: He, Qiao, et al.
Publicado: (2021)

Prevalence and molecular epidemiology characteristics of carbapenem-resistant Escherichia coli in Heilongjiang Province, China
por: Cheng, Ping, et al.
Publicado: (2019)

Resistance mechanisms and molecular epidemiology of carbapenem-nonsusceptible Escherichia coli in Taiwan, 2012-2015
por: Chang, Ya-Ting, et al.
Publicado: (2019)

The Resistance Mechanism Governs Physiological Adaptation of Escherichia coli to Growth With Sublethal Concentrations of Carbapenem
por: Schäfer, Franca, et al.
Publicado: (2022)

Molecular epidemiology and genomic insights into the transmission of carbapenem-resistant NDM-producing Escherichia coli
por: Xu, Juan, et al.
Publicado: (2023)

Prevalence of main quinolones and carbapenems resistance genes in clinical and veterinary Escherichia coli strains
por: Karshenas, Ali Ehsan, et al.
Publicado: (2022)

Antibacterial evaluation of plants extracts against ampicillin-resistant Escherichia coli (E. coli) by microcalorimetry and principal component analysis
por: Xu, Zhuo, et al.
Publicado: (2019)

Pleural fluid penetration of moxifloxacin and doripenem: An experimental model of empyema
por: Calik, Mustafa, et al.
Publicado: (2019)

Doripenem in the Treatment of Patients with Nosocomial Pneumonia: A Meta-Analysis
por: Huang, Chienhsiu, et al.
Publicado: (2022)

Isotherm data for adsorption of amoxicillin, ampicillin, and doripenem onto bentonite
por: Yeo, Jason Yi Juang, et al.
Publicado: (2023)

Antibacterial and Antidiarrheal Activities of Plant Products against Enterotoxinogenic Escherichia coli
por: Dubreuil, J. Daniel
Publicado: (2013)

Antibacterial activity of human defensins against Staphylococcus aureus and Escherichia coli
por: Bolatchiev, Albert
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_st185ssi46dsjjhnu7af4jbbif